SKY-0515

skyhawk-therapeutics-reports-promising-results-for-sky-0515-in-huntington-s-disease

Skyhawk Therapeutics Reports Promising Results for SKY-0515 in Huntington’s Disease

Editorial 17 September, 2025

Skyhawk Therapeutics, Inc. announced encouraging results from its first interim analysis of the Phase...

skyhawk-therapeutics-reports-breakthrough-results-for-sky-0515

Skyhawk Therapeutics Reports Breakthrough Results for SKY-0515

Editorial 17 September, 2025

BREAKING: Skyhawk Therapeutics has just announced promising interim results from its Phase 1 clinical...